4.5 Article

Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Health Care Sciences & Services

Health-care utilization and outcomes of patients at high risk of invasive fungal infection

Rao Fu et al.

CLINICOECONOMICS AND OUTCOMES RESEARCH (2018)

Letter Microbiology

Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience

George R. Thompson et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Medicine, General & Internal

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Oliver A. Cornely et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

Andrew J. Ullmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Immunology

Epidemiology and outcome of zygomycosis: A review of 929 reported cases

MM Roden et al.

CLINICAL INFECTIOUS DISEASES (2005)

Review Immunology

Aspergillosis case - Fatality rate: Systematic review of the literature

SJ Lin et al.

CLINICAL INFECTIOUS DISEASES (2001)